Log in
Enquire now
‌

US Patent 10774117 Compositions relating to a mutant

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10774117
Date of Patent
September 15, 2020
Patent Application Number
15648092
Date Filed
July 12, 2017
Patent Citations
‌
US Patent 10047404 Highly conserved tuf genes and their use to generate probes and primers for detection of coagulase-negative
‌
US Patent 10093722 Nucleotide sequences, vectors and host cells
‌
US Patent 10117933 Antibodies against
‌
US Patent 10160797 Antibodies against
‌
US Patent 10130694 Immunogenic composition
‌
US Patent 10597428 Compositions relating to a mutant clostridium difficile toxin and methods thereof
‌
US Patent 10357557 Isolated polypeptide of the toxin A and toxin B proteins of
‌
US Patent 10046040 Multivalent live vector vaccine against
Patent Citations Received
‌
US Patent 11952597 Compositions and methods relating to a mutant
0
‌
US Patent 10982198 Compositions and methods relating to a mutant
‌
US Patent 11535652 Compositions relating to a mutant clostridium difficile toxin and methods thereof
Patent Primary Examiner
‌
Jana A Hines
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10774117 Compositions relating to a mutant

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.